Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Sanofi SA | 22 |
| 2 | Children's Hospital of Philadelphia | 2 |
| 3 | Columbia University | 2 |
| 4 | Affinity (Shanghai) Biopharmaceutical Co Ltd | 1 |
| 5 | DSM Firmenich AG | 1 |
| 6 | International Flavors and Fragrances Inc | 1 |
| 7 | The Pennsylvania State University | 1 |
| 8 | The University of Tokyo | 1 |
| 9 | Yale University | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 40 |
| 2 | C07K | Peptides | 28 |
| 3 | A61P | Therapeutic activity (drug indications) | 14 |
| 4 | A61B | 10 | |
| 5 | A61L | Sterilising / disinfecting materials | 8 |
| 6 | G01N | Investigating / analysing materials | 8 |
| 7 | A61Q | Cosmetics, personal care | 6 |
| 8 | A23L | Foods and beverages (general) | 5 |
| 9 | C07D | Heterocyclic compounds | 4 |
| 10 | C12N | Microorganisms, enzymes | 4 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee |
|---|---|---|
| THE TOTAL SYNTHESIS OF GLUCOSEPANE AND RELATED CHEMICAL REACTIONS, COMPOUNDS AND COMPOSITIONS OBTAINED THEREFROM AND METHODS OF TREATMENT | 2017 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Vincent M. Monnier | Case Western Reserve University | 7 |
| 2 | David R. Sell | Case Western Reserve University | 6 |
| 3 | Helen L. Birch | University College London | 5 |
| 4 | Anthony Nash | University College London | 5 |
| 5 | Nora H. de Leeuw | University College London | 5 |
| 6 | Saul Genuth | Case Western Reserve University | 4 |
| 7 | Wanjie Sun | George Washington University | 4 |
| 8 | Naila Rabbani | University of Warwick | 3 |
| 9 | Thomas A. Collier | University College London | 3 |
| 10 | John M. Lachin | George Washington University | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease | 2015 | 201 | Connective tissue disorders research |
| Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes | 2014 | 147 | Diabetes, Cardiovascular Risks, and Lipoproteins |
| Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications | 2013 | 73 | Natural Antidiabetic Agents Studies |
| Assessing glycation‐mediated changes in human cortical bone with Raman spectroscopy | 2018 | 63 | Bone health and osteoporosis research |
| The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes | 2012 | 60 | Diabetes, Cardiovascular Risks, and Lipoproteins |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Glucosepan?
Which organizations hold the most patents related to Glucosepan?
What is the patent landscape for Glucosepan in recent years?
Who are the leading researchers publishing on Glucosepan?
What are the main research and patent focus areas for Glucosepan?